Volume 75, Issue 1 pp. 163-164
Letter

Treatment of intractable epilepsy in tuberous sclerosis complex with everolimus is not yet evidence-based

Iris E. Overwater MSc

Iris E. Overwater MSc

Departments of Neurology, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands

Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands

Search for more papers by this author
André B. Rietman MSc

André B. Rietman MSc

Departments of Neurology, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands

Pediatrics, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands

Search for more papers by this author
Ype Elgersma PhD

Ype Elgersma PhD

Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands

Search for more papers by this author
Marie-Claire Y. de Wit MD, PhD

Marie-Claire Y. de Wit MD, PhD

Departments of Neurology, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands

Search for more papers by this author
First published: 15 November 2013
Citations: 5
No abstract is available for this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me